Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02301260 · ClinicalTrials.gov registry record · NA

Speed of Processing Training to Improve Cognition in Multiple Sclerosis

A NA study of Multiple Sclerosis, sponsored by Kessler Foundation.

Completed
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT02301260 is a NA study of Multiple Sclerosis that has completed, run by Kessler Foundation. The registered enrollment target is 100 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02301260, a NA study of Multiple Sclerosis, has completed, sponsored by Kessler Foundation.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to investigate the effectiveness of a computerized technique designed to improve processing speed (i.e. the amount of time it takes for a person's brain to process information) in a multiple sclerosis (MS) population. The study is designed to study how well this technique can help people with MS increase their processing speed and their ability to function better in everyday life. This treatment protocol has been studied extensively with older adults, showing improvements on standard laboratory measures of processing speed and performance of activities of daily living.

Conditions Studied

Interventions

  • BEHAVIORAL Placebo Control
  • BEHAVIORAL Speed of Processing Training (SPT)

Study Locations (1)

New Jersey

  • Kessler Foundation - West Orange

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2014-04
Est. Completion 2020-02
Phase NA

Sponsor

Kessler Foundation

104 total trials

What the Registry Record Tells You About NCT02301260

The ClinicalTrials.gov registry entry for NCT02301260 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (83% lower). The listed sponsor is Kessler Foundation, which has 104 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which Placebo Control is the first listed.

NCT02301260 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT02301260 about?

NCT02301260 is a clinical study titled "Speed of Processing Training to Improve Cognition in Multiple Sclerosis". The purpose of this research study is to investigate the effectiveness of a computerized technique designed to improve processing speed (i.e. the amount of time it takes for a person's brain to process information) in a multiple sclerosis (MS) population. The study is designed to study how well this...

What is the current status of trial NCT02301260?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2014-04. Estimated completion is 2020-02.

What conditions does trial NCT02301260 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT02301260?

The interventions under investigation include: Placebo Control (BEHAVIORAL), Speed of Processing Training (SPT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT02301260?

This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02301260 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.